Skip to Content

66 Y (Lamivudine 150 mg)

Pill with imprint 66 Y is White, Elliptical / Oval and has been identified as Lamivudine 150 mg. It is supplied by Aurobindo Pharma USA, Inc..

Lamivudine is used in the treatment of hepatitis b; hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 66 Y

Lamivudine

Imprint
66 Y
Strength
150 mg
Color
White
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Aurobindo Pharma USA, Inc.

Labelers / Repackagers

NDC CodeLabeler / Repackager
65862-0552 Aurobindo Pharma Limited
68084-0578 Amerisource Health Services

Get help with Imprint Code FAQs.

Related Images for "66 Y"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.